Advanced Biomed Inc. (NASDAQ:ADVB) Sees Large Decrease in Short Interest

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 16,357 shares, a drop of 56.2% from the August 15th total of 37,364 shares. Based on an average daily volume of 272,520 shares, the short-interest ratio is presently 0.1 days. Currently, 1.4% of the company’s stock are sold short.

Advanced Biomed Stock Down 0.7%

Shares of NASDAQ:ADVB traded down $0.06 on Monday, reaching $8.13. 9,296 shares of the company’s stock were exchanged, compared to its average volume of 850,294. The business’s 50-day moving average is $8.56 and its two-hundred day moving average is $6.14. Advanced Biomed has a fifty-two week low of $3.61 and a fifty-two week high of $24.23. The firm has a market capitalization of $13.41 million, a price-to-earnings ratio of 1.69 and a beta of -0.29.

Wall Street Analyst Weigh In

ADVB has been the subject of several research analyst reports. Weiss Ratings raised Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, July 23rd. Wall Street Zen raised Advanced Biomed to a “hold” rating in a report on Saturday, August 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.